Publication: A novel agent for myeloma causing toxic keratopathy, belantamab mafodotin: a case report and literature review
Program
KU-Authors
KU Authors
Co-Authors
Kurt, Rengin Aslıhan
Gören, Deniz
Karadeniz, Sehnaz
Arat, Mutlu
Publication Date
Language
Type
Embargo Status
Journal Title
Journal ISSN
Volume Title
Alternative Title
Belantamabe-mafodotina, um novo agente para mieloma, causando ceratopatia tóxica: relato de caso e revisão da literatura
Abstract
A 60-year-old-male with refractory relapsed multiple myeloma presented with redness, pain, foreign body sensation, and blurred vision in both eyes that gradually increased after his third belantamab mafotodin infusion. Biomicroscopy revealed bilateral microcyst-like epithelial changes and epithelial crystal-like deposits, whereas in vivo confocal microscopy revealed intraepithelial and subepithelial hyperreflective deposits in corneal epithelium. Belantamab mafodotin therapy was discontinued for seven weeks due to corneal toxicity, which cleared progressively. We aim to demonstrate belantamab mafodotin-related corneal toxicity that may be detected using slit lamp and in vivo confocal biomicroscopy. © This content is licensed under a Creative Commons Attributions 4.0 International License.
Source
Publisher
Conselho Brasileiro de Oftalmologia
Subject
Ophthalmology
Citation
Has Part
Source
Arquivos Brasileiros de Oftalmologia
Book Series Title
Edition
DOI
10.5935/0004-2749.2021-0358